Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,867 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial.
Skeith L, Malinowski AK, El-Chaâr D, Chan WS, Donnelly J, Chauleur C, Ganzevoort W, Wood S, Dubois S, McCarthy C, Buchmuller A, Wiegers H, Gibson PS, Ní Áinle F, Middeldorp S, Duffett L, Bates SM, Garven A, Baxter J, Lethebe BC, Rodger MA; Pilot PARTUM Group. Skeith L, et al. Lancet Haematol. 2025 Jan 15:S2352-3026(24)00338-7. doi: 10.1016/S2352-3026(24)00338-7. Online ahead of print. Lancet Haematol. 2025. PMID: 39827892
[Integrative medicine : what's new in 2024].
Ungarelli-McEvoy C, Ogal M, Fleury M, Schlaeppi M, Berna C, Zurron N, Fernandez A. Ungarelli-McEvoy C, et al. Among authors: fernandez a. Rev Med Suisse. 2025 Jan 15;21(900-1):53-55. doi: 10.53738/REVMED.2025.21.900-1.53. Rev Med Suisse. 2025. PMID: 39812287 Review. French.
Michigan tobacco cessation champions: A rapid qualitative analysis.
Tomlinson DC, Wilkins C, Bayrakdarian N, Dolecki F Jr, Bonar EE, Fernandez A, Tzilos Wernette G, Coughlin LN. Tomlinson DC, et al. Among authors: fernandez a. Prev Med Rep. 2024 Dec 12;49:102945. doi: 10.1016/j.pmedr.2024.102945. eCollection 2025 Jan. Prev Med Rep. 2024. PMID: 39807181 Free PMC article.
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Fiorentino D, Mangold AR, Werth VP, Christopher-Stine L, Femia A, Chu M, Musiek ACM, Sluzevich JC, Graham LV, Fernandez AP, Aggarwal R, Rieger K, Page KM, Li X, Hyde C, Rath N, Sloan A, Oemar B, Banerjee A, Salganik M, Banfield C, Neelakantan S, Beebe JS, Vincent MS, Peeva E, Vleugels RA. Fiorentino D, et al. Among authors: fernandez ap. Lancet. 2025 Jan 11;405(10473):137-146. doi: 10.1016/S0140-6736(24)02071-3. Lancet. 2025. PMID: 39798982 Clinical Trial.
5,867 results